Critical Limb Ischemia Treatment Market By Treatment (Devices and Medications): Global Industry Perspective, Comprehensive Analysis, and Forecast, 2018–2025

Global critical limb ischemia treatment market expected to generate USD 5,390 million by 2025, at a CAGR of 8.1% between 2019 and 2025. Critical limb ischemia is a chronic disease of peripheral arteries, in which chronic inflammation allied with atherosclerosis causes abridged flow of blood and oxygen to the legs, hands, and feet.

08-Jul-2019 | Number of pages: 120 | Report Code: ZMR-4340 | Report Format : | Status : Published

Analysis

Critical limb ischemia is a chronic disease of peripheral arteries, in which chronic inflammation allied with atherosclerosis causes abridged flow of blood and oxygen to the legs, hands, and feet. This, in turn, leads to chronic pain and soreness. The key factors responsible for critical limb ischemia disease include aging, as geriatric people are more susceptible to the development of these conditions, diabetes, obesity, extremely high cholesterol levels, sedentary lifestyle, smoking, and increased blood pressure. The common symptoms of critical limb ischemia disease are gangrene, ischemic rest pain, loss of tissue, etc. The growing prevalence of critical limb ischemia is expected to drive the demand for its treatment, which, in turn, is predicted to propel the growth of the critical limb ischemia treatment market globally. In the U.S., about 2 to 3 million people are suffering from critical limb ischemia. Furthermore, the growing healthcare spending and increasing number of new drug development studies are also expected to boost the development of the critical limb ischemia treatment market globally. Additionally, the growing competition among the key players operating in the global critical limb ischemia market for the development of advanced therapy is anticipated to further propel the market growth in the future.

 

The critical limb ischemia treatment market is fragmented on the basis of treatment and region. By treatment, the market is segmented into two major categories—devices and medications. On the basis of devices, the global critical limb ischemia treatment market includes peripheral dilatation systems, and embolic protection devices. The peripheral dilatation systems are further classified into vascular stents, and balloon dilators. The medications segment of the critical limb ischemia treatment market includes antihypertensive agents, antiplatelet drugs, antithrombotic agents, lipid-lowering agents, and others. In terms of growth rate, the critical limb ischemia devices segment is expected to register the highest CAGR in the global market over the forecasted time span.

North American and European regions dominated the global critical limb ischemia treatment market with substantial market shares in the year 2018. This can be attributed to the high obesity rate, growing ischemia diseases due to unhealthy lifestyles across North America. The Asia Pacific region is expected to register the highest growth in the global critical limb ischemia treatment market in the years to come, owing to the increasing awareness among the regional population about the critical limb ischemia.

Some major players of the global critical limb ischemia treatment market are Boston Scientific Corporation, Medtronic, Cesca Therapeutics, Pluristem Therapeutics, Abbott Laboratories, Rexgenero, Micro Medical Solutions, LimFlow, and Cardiovascular Systems.


Related Reports

Dexamethasone Market by Formulation type (liquid, Tablet, Solution for injection, Other), by Patient type (Adult, Pediatric, and Geriatric), by Application (Anti-inflammatory and immunosuppressant effects, Respiratory Distress Syndrome, COVID-19, and Others), and End user (Hospitals, Clinics, Pharmacy & Drug Stores, and Online Pharmacies) – Global Industry Perspective Comprehensive Analysis and Forecast, 2020-2026

Aug-2020 | Price : $ 4199.00 | Pages: 135 | Report Code: ZMR-5369 | Report Format:

The report covers forecast and analysis for the Dexamethasone market on a global and regional level. The study provides historic data from 2016 to 2019 along with a forecast from 2020 to 2026 based on revenue (USD Billion). The study includes drivers and restraints for the Dexamethasone market alo...Read More

Over-the-Counter Drugs Market - By Product (Cough & Flu Products, Analgesics, Cold, Weight Loss Products, Mineral and Vitamin Supplements, Gastrointestinal Products, Ophthalmic Products, Skin Products, and Others): Global Industry Perspective, Comprehensive Analysis and Forecast, 2020 - 2026

Aug-2020 | Price : $ 4199.00 | Pages: 110 | Report Code: ZMR-5362 | Report Format:

The report covers forecast and analysis for the over-the-counter drugs market on a global and regional level. The study provides historic data from 2016 to 2019 along with a forecast from 2020 to 2026 based on revenue (USD Million). The study includes drivers and restraints for the over-the-counte...Read More

Remdesivir Market by Dosage (2.5mg, 5mg, 100mg, 200mg), by Patient (Adult, Pediatric, and Geriatric), by Application (Ebola, SARS-COV, MERS-COV, COVID-19), and End user (Hospitals, Clinics, Pharmacy & Drug Stores, and Online Pharmacies) – Global Industry Perspective Comprehensive Analysis and Forecast, 2020-2026

Aug-2020 | Price : $ 4199.00 | Pages: 135 | Report Code: ZMR-5358 | Report Format:

The report covers forecast and analysis for the Remdesivir market on a global and regional level. The study provides historic data from 2016 to 2019 along with a forecast from 2020 to 2026 based on revenue (USD Billion). The study includes drivers and restraints for the Remdesivir market along wit...Read More

Immunity Booster Market - by Nature (Organic, Conventional), by Source (Plant-based, Animal-based, Other), by Form (Tablets, Capsules, Powder, Liquid), and Sales Channel (Hypermarkets/Supermarkets, Specialty Stores, Pharmacy & Drug Stores, and Online Retail) – Global Industry Perspective Comprehensive Analysis and Forecast, 2020-2026

Aug-2020 | Price : $ 4199.00 | Pages: 135 | Report Code: ZMR-5357 | Report Format:

The report covers forecast and analysis for the Immunity booster market on a global and regional level. The study provides historic data from 2016 to 2019 along with a forecast from 2020 to 2026 based on revenue (USD Billion). The study includes drivers and restraints for the Immunity booster mark...Read More

Hydroxychloroquine Market - By Type (USP Standards Grade, Pharmaceutical Standards Grade, EP Standards Grade, and Others), By Application (Rheumatoid Arthritis, Skin Lesions, Systemic Lupus Erythematosus, Chronic Discoid Lupus Erythematosus, and Others), and By Region - Global Industry Perspective, Comprehensive Analysis, and Forecast, 2019 – 2025

Apr-2020 | Price : $ 4199.00 | Pages: 110 | Report Code: ZMR-5346 | Report Format:

The global Hydroxychloroquine market value was estimated at 542 (USD Million) in 2019 and is projected to hit 5,000 (USD Million) by 2025 growing at a CAGR of over 33% during the period from 2019 to 2025. The report offers valuation and analysis of the Hydroxychloroquine market on a global as well...Read More

Request Brochure

COVID-19

A Global Pandemic

Request the coronavirus impact analysis across industries and market

Request impact analysis on this market
Why Choose Us ?

24/5 Research support

Resolved your research queries from industry expert. Request for a research sample before report purchase.

Custom research service

Ask the Analyst to customize an exclusive study to serve your research needs.

Quality & Accuracy

Zion Market Research reports offers best quality reports based on various authentic and accurate data findings.

Customer Satisfaction

We ensure that our client's all research needs are met with customized, in-depth analysis solutions.

Information security

We never share your personal and confidential information. Your personal information is safe and secure with us.